Cargando…
Tissue distribution of sprifermin (recombinant human fibroblast growth factor 18) in the rat following intravenous and intra-articular injection
OBJECTIVE: Fibroblast growth factor 18 (FGF18) is involved in chondrogenesis and articular cartilage repair. We investigated tissue distribution and pharmacokinetics of radioactive [(3)H]sprifermin, a recombinant human FGF18, in rats after a single intravenous (i.v.) or intra-articular (i.a.) inject...
Autores principales: | Ladel, C.H., Barbero, L., Riva, S., Guehring, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718268/ https://www.ncbi.nlm.nih.gov/pubmed/36474684 http://dx.doi.org/10.1016/j.ocarto.2020.100068 |
Ejemplares similares
-
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study
por: Eckstein, Felix, et al.
Publicado: (2021) -
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo
por: Reker, Ditte, et al.
Publicado: (2017) -
Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo
por: Reker, D., et al.
Publicado: (2020) -
Efficacy and safety of sprifermin injection for knee osteoarthritis treatment: a meta-analysis
por: Zeng, Ni, et al.
Publicado: (2021) -
(99m)Tc-NTP 15-5 is a companion radiotracer for assessing joint functional response to sprifermin (rhFGF-18) in a murine osteoarthritis model
por: Briat, Arnaud, et al.
Publicado: (2022)